版本:
中国

BRIEF-FDA grants Bayer priority review for investigational compound Copanlisib

May 17 Bayer Ag

* FDA grants Bayer priority review for investigational compound Copanlisib in Follicular Lymphoma

* U.S. Food and drug administration has granted priority review designation for new drug application for Copanlisib Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐